Chemesis’ Puerto Rican Operations Bolstered by Prestigious Awards, Plus Exclusive Interview with Board Member Deepak Anand
Uncategorized May 3, 2019 MJ Shareholders
Tony Deyes
May 3rd, 2019
Uncategorized
Chemesis International Inc. (CSE: CSI, OTC: CADMF, FRA: CWAA), a Vancouver-based cannabis company with operations in California, Puerto Rico, and Colombia announced April 5th that its Puerto Rican subsidiary, Natural Ventures has been awarded Best Topical, Best Tincture, and Best Vaporizer by the FreeJuana Foundation, a non-profit dedicated to the promotion of responsible cannabis usage and education about its medical benefits.
The awards were handed out at an annual gala recognizing Puerto Rican industry leaders who demonstrate a commitment to superior patient care and developing the cannabis industry on the Caribbean island. Winners were chosen through a survey of dispensary owners, industry leaders, and certified medical cannabis patients, making them truly representative. FreeJuana is Puerto Rico’s first and largest pro-cannabis organization which hosts an annual march to draw awareness to the benefits of cannabis, in addition to bringing together experts and policymakers to help shape Puerto Rico’s cannabis regulations.
Commenting on the awards, Chemesis CEO, Edgar Montero said, “We are extremely honoured to have received such high recognition for our continued dedication to producing products that are of the highest quality. Receiving this recognition through a survey of our peers is validation that our team has developed the right approach to producing our finished goods. Chemesis will continue to employ these strategies and maintain its consistency in all areas of our business.”
Natural Ventures is a seed to sale medical cannabis company, operating in Caguas, Puerto Rico since early 2017 with 100,000 square feet of cultivation space and an additional 35,000 sq. ft. dedicated to manufacturing edibles and other cannabis-infused products. Puerto Rico legalized medical cannabis for qualifying health conditions in 2015, but only permits the sale of derivatives products. Chemesis’ wholly-owned Puerto Rican subsidiary, Chemesis PR, acquired an 80% stake in Natural Ventures last August.
Awards Raise Profile of Viverian Launch
On the heels of the award, Chemesis announced the launch of Viverian, an all-natural CBD product line, after acquiring Viverian’s CBD product catalogue in December.
Viverian is a hemp-derived CBD product line that promotes healthy living and offers quick and easy consumption methods. The line includes tinctures as well as capsules designed for sleep, relaxation, improved concentration, relief for discomfort, and improved overall health & wellness, which are lab-tested, THC free, with 100% botanical ingredients.
New regulations from the Puerto Rican Department of Health allow licensed manufacturing facilities to incorporate hemp-derived CBD in to its portfolios as long as the products are entered in to the tracking system and tested through licensed labs located in Puerto Rico. Prior to the adoption of the US Farm Bill earlier this year, hemp still carried the same legal classification as cannabis containing THC. The US was the only industrialized country with a ban on hemp, and the new regulations will enable the cultivation of industrial hemp crops. Hemp-derived CBD is the fastest-growth segment of the CBD market, and the declassification is expected to address the current shortage of CBD within the industry.
Natural Ventures anticipates Viverian products to hit dispensaries before the end of April and will also offer contract manufacturing services for other licensees in Puerto Rico.
“Natural Ventures is a key part of Chemesis’ long term strategy to build a major presence in Latin America, and by launching Viverian, it allows penetration into the Puerto Rican CBD market,” added Montero. “Chemesis believes it has an advantage in the Latin American CBD market as it is able to leverage its state-of-the-art facility, its previously announced partnership with First Medical that brings up to 6,000 acres of hemp cultivation, and its all-natural Viverian CBD product catalogue.”
Chemesis’ relationships with industry and political leaders in Puerto Rico, Colombia, as well as California, have positioned it as a strategic first-mover in all three jurisdictions, giving it an advantage over much of its competition.
For more information, keep watching this page or visit https://chemesis.com/
And connect with Chemesis in social media:
Disclaimer
The above article is sponsored content. Emerging Growth LLC, which owns CannabisFN.com and CFN Media, has been hired to create awareness. Please follow the link below to view our full disclosure outlining our compensation: http://www.cannabisfn.com/legal-disclaimer/
About Tony Deyes
MJ Shareholders
MJShareholders.com is the largest dedicated financial network and leading corporate communications firm serving the legal cannabis industry. Our network aims to connect public marijuana companies with these focused cannabis audiences across the US and Canada that are critical for growth: Short and long term cannabis investors Active funding sources Mainstream media Business leaders Cannabis consumers
